S&P BSE 400 MidSmallCap Index PB	4.4
S&P BSE 400 MidSmallCap Index PE	32.6
S&P BSE 400 MidSmallCap Index DIV	0.8
S&P BSE 400 MidSmallCap Index EPS	365.1

S&P BSE 400 MidSmallCap Index News and Updates

Keep track of all breaking news on S&P BSE 400 MidSmallCap Index from all sources in a single place.

Lupin Ltd.

03 Sep 2025, 03:56PM

1951.10

3.25%

Lupin gets USFDA nod for generic risperidone extended-release injectable suspension

Business Line

The medicine had estimated annual sales of $190 million in the US

Sharekhan released a Buy report for Lupin Ltd. with a price target of 2400.0 on 21 Aug, 2025.

Lupin share price rises 3% as USFDA okays schizophrenia drug; details

Business Standard | 03 Sep 2025, 02:43PM

Waaree Energies Ltd.

03 Sep 2025, 03:37PM

3224.00

0.78%

Waaree Energies acquires 64% stake in transformer manufacturer Kotsons

Business Line

The shares of Waaree Energies Limited were trading at 3,216.30 up by 17.20 or 0.54% on the NSE today at 3.05 pm

Number of FII/FPI investors increased from 105 to 187 in Jun 2025 qtr.

Caplin Point Laboratories Ltd.

03 Sep 2025, 02:48PM

2161.00

1.58%

Caplin Point's unit gets USFDA nod for generic milrinone lactate injection

Business Standard

Pharma firm Caplin Point Laboratories Ltd on Wednesday said its arm Caplin Steriles Ltd has received final approval from the US health regulator for its generic milrinone lactate in 5 per cent dextrose injection indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. The approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) milrinone lactate in 5 per cent Dextrose Injection of strengths 20 mg/100 mL and 40 mg/200 mL in single-dose infusion bags, Caplin Point Laboratories said in a regulatory filing. The approved injection is a generic therapeutic equivalent version of the reference listed drug PRIMACOR in dextrose 5 per cent, by Sanofi Aventis US LLC, it added. Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure, the company said. Citing IQVIA (IMS Health) data, the company said milrinone lactate in 5 per cent...

Caplin Point Laboratories Ltd. is trading above all available SMAs

Kaynes Technology India Ltd.

03 Sep 2025, 02:28PM

6744.00

2.60%

Kaynes Tech OSAT Plant: First Set Of Samples For Anchor Client To Be Ready This Month

NDTV Profit

Kaynes Tech and CG Power have emerged as two key players in India's push to manufacture semiconductors domestically, with both companies betting heavily on OSAT plants in Sanand, Gujarat.

Kaynes Technology In.. has an average target of 6833.50 from 2 brokers.

Zydus Wellness Ltd.

03 Sep 2025, 01:04PM

2328.40

3.32%

Zydus Wellness' Comfort Click Acquisition Is Earnings Accretive Says Anand Rathi Maintaining 'Buy'

NDTV Profit

Anand Rathi retains a Buy with a higher 12-month target price, 30x Sep'27e earnings per share.

Zydus Wellness Ltd. has gained 49.13% in the last 6 Months

YES Bank Ltd.

03 Sep 2025, 12:57PM

20.35

4.09%

Yes Bank stock up 3% on CCI nod for this deal; check more details inside

Business Standard

Yes Bank's share price was quoting 3.3 per cent higher at 20.2 per share against the previous close of 19.55 on the NSE

YES Bank Ltd. has an average target of 18.50 from 2 brokers.

India competition regulator approves SMBC's stake buy in Yes Bank

Business Standard | 02 Sep 2025, 06:36PM 1 more

L&T Technology Services Ltd.

03 Sep 2025, 12:14PM

4195.40

-0.27%

LTTS partners with SiMa.ai to develop physical AI solutions

Business Line

The partnership includes establishing a scalable product support framework and joint go-to-market strategies to accelerate AI technology adoption worldwide